Yerukala S. et. al., Identifying a miRNA signature for predicting the stage of breast cancer, https://doi.org/10.1038/s41598-018-34604-3, Sci. Reports, Oct 31, 2018 ➔

Li Y. et. al., EZH2-DNMT1-mediated epigenetic silencing of miR-142-3p promotes metastasis through targeting ZEB2 in nasopharyngeal carcinoma, https://doi.org/10.1038/s41418-018-0208-2, Cell Death and Differentiation, Oct 23, 2018 ➔

Dhage S. et. al., A genomic ruler to assess oncogenic transition between breast tumor and stroma, 10.1371/journal.pone.0205602, PLoS ONE, Oct 16, 2018 ➔

Pillar N. et. al., Comparison of breast cancer metastasis models reveals a possible mechanism of tumor aggressiveness, https://doi.org/10.1038/s41419-018-1094-8, Cell Death & Disease, Oct 10, 2018 ➔

Wenzl K. et. al., Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphoma, https://doi.org/10.1038/s41408-018-0130-3, Blood Cancer, Oct 09, 2018 ➔

Medler T.R. et. al., Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy, https://doi.org/10.1016/j.ccell.2018.09.003, Cancer Cell, Oct 08, 2018 ➔

Kahn S.A. et. al., Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma, https://doi.org/10.1038/s41467-018-06564-9, Nature Commun., Oct 08, 2018 ➔

House R. et. al., Smoking-induced control of miR-133a-3p alters the expression of EGFR and HuR in HPV-infected oropharyngeal cancer, 10.1371/journal.pone.0205077, PLoS ONE, Oct 05, 2018 ➔

Houot R. et. al., Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma: a phase II LYSA study, https://doi.org/10.1038/s41375-018-0282-y, Leukemia, Oct 05, 2018 ➔

Arthur S. E. et. al., Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma, https://doi.org/10.1038/s41467-018-06354-3, Nature Commun., Oct 01, 2018 ➔

Hwang J. et. al., MicroRNA Expression Profiles in Gastric Carcinogenesis, https://doi.org/10.1038/s41598-018-32782-8, Sci. Reports, Sep 26, 2018 ➔

Fattore L., et. al., Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma, https://doi.org/10.1038/s41418-018-0205-5, Cell Death and Differentiation, Sep 25, 2018 ➔

Schultz S. et. al., Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers, 10.1186/s12920-018-0403-5, BMC. Med. Genomics, Sep 20, 2018 ➔

Roszik J. et. al., Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy, 10.3389/fimmu.2018.02102, Front. Immunol, Sep 19, 2018 ➔

Burgo M.A. et. al., Ruxolitinib inhibits cyclosporine-induced proliferation of cutaneous squamous cell carcinoma, 10.1172/jci.insight.120750, JCI Insight, Sep 06, 2018 ➔